Physician

Haresh Kumar, M.D

According to 2025 Medicare claims, Haresh Kumar, M.D (NPI: 1518087576) practices nephrology in the Victoria, TX market, with the plurality of this provider's patient population coming from Victoria, TX. This provider's primary affiliated billing organization is VICTORIA NEPHROLOGY ASSOCIATES LLC (NPI: 1023398989; TIN: 453050693) and primary practice location at 77901-3933. Kumar is affiliated with the The Rural Advantage LLC (ACO ID: A5257), Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), and Main Street Rural Health Cottonwood ACO LLC (ACO ID: A5439), participating under the MSSP model.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 558 traditional Medicare patients, billed 3,140 HCPCS/CPT codes, and received $265,209 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,536 prescription claims across 272 beneficiaries totaling $228,057 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2023 DME data shows 44 claims. Open Payments data shows 2 records totaling $44. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $415,975 to $265,209. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $184,133 and ending at $228,057. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,178 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	934	5,276	$415,975
2016	1,056	5,861	$480,175
2017	882	4,617	$409,222
2018	806	4,229	$380,191
2019	782	4,573	$403,281
2020	689	3,832	$369,067
2021	629	3,676	$379,902
2022	573	3,072	$301,471
2023	578	2,967	$295,413
2024	558	3,140	$265,209

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	265	2,107	$184,133
2016	240	1,934	$251,088
2017	219	1,743	$182,758
2018	207	1,409	$140,196
2019	238	1,435	$161,818
2020	213	1,302	$193,976
2021	239	1,392	$173,907
2022	217	1,356	$338,582
2023	230	1,429	$293,085
2024	272	1,536	$228,057

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	42	$2,100
2016	N/R	11	$189
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	44	$719
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	137	188	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	279	597	$92
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	157	370	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	174	984	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	204	481	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	63	1,575	$186,405
Sevelamer Carbonate	Sevelamer Carbonate	52	3,240	$14,632
Potassium Chloride	Potassium Chloride	72	3,372	$1,423
Amlodipine Besylate	Amlodipine Besylate	301	15,999	$1,234
Torsemide	Torsemide	45	1,790	$1,065

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$44	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Haresh Kumar, M.D?

Tedicare shows public-source Medicare data for Haresh Kumar, M.D (NPI 1518087576), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Haresh Kumar, M.D have ACO affiliation data?

Haresh Kumar, M.D is shown with ACO affiliation data for The Rural Advantage LLC (MSSP, ACO ID A5257), Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), and Main Street Rural Health Cottonwood ACO LLC (MSSP, ACO ID A5439).

What billing organization is linked to Haresh Kumar, M.D?

Haresh Kumar, M.D is linked to VICTORIA NEPHROLOGY ASSOCIATES LLC (billing NPI 1023398989) in the available physician profile data.

Does Haresh Kumar, M.D have Open Payments data?

Haresh Kumar, M.D has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.